Skip to main content

Humphrey Rachel's Form 4 filing

Pyxis Oncology, Inc.PYXS · filed Mar 25, 2026

Accession no.
0000905148-26-001434
Filed
Mar 25, 2026
Trade date
Apr 14-21, 2025
Filing delay
345 daysLate
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $15.9K. It was filed 345 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Humphrey RachelCIK 0001579781Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 14, 2025Common StockSSaleDisposed−1,400$0.97F2,F3−$1,35895,405Direct
Apr 17, 2025Common StockSSaleDisposed−200$0.97−$19495,205Direct
Apr 21, 2025Common StockSSaleDisposed−13,896$1.03F2,F4−$14,312.8881,309Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 through 4 of this Form 4.

Referenced by the price of 2 transactions in Table I.

F3

The transaction was executed in multiple trades in prices ranging from $0.97 to $0.98.

Referenced by the price of 1 transaction in Table I.

F4

The transaction was executed in multiple trades in prices ranging from $0.97 to $1.09.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)